Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Cash Flows from Operating Activities
Net income	$ 8,102	$ 4,909
Adjustments to reconcile net income to net cash from operating activities:
Depreciation	709	679
Amortization of premiums on available-for-sale securities, net	578	512
Servicing rights amortization and impairment	26	505
Amortization of core deposit intangible	199	140
Amortization of customer list intangible	31	31
Net amortization (accretion) of fair value adjustments	(1,015)	70
Amortization of subordinated note issuance costs	28
Stock-based compensation expense	213	225
Provision for loan loss	580	1,700	$ 3,444
Gain on sale of loans held for sale	(697)	(1,046)
Originations of loans held for sale	(26,161)	(35,536)
Proceeds from sale of loans held for sale	28,512	36,811
Net gain on sale of other assets owned	(5)	(25)
Gain on sales of securities available-for-sale		(293)
Increase in cash surrender value of bank owned life insurance	(157)	(139)
Change in other assets and other liabilities, net	(3,046)	(2,098)
Net cash provided by operating activities	7,897	6,445
Activity in available-for-sale securities:
Maturities, prepayments and calls	13,762	15,897
Sales		7,773
Purchases	(19,344)	(76,081)
Activity in other securities, at cost:
Purchases	(406)
Change in interest-bearing time deposits	2,236	248
Proceeds from sale of other assets owned	164	99
Additions to premises and equipment	(448)	(318)
Loan originations and principal collections, net	(104,478)	(39,722)
Net cash used in investing activities	(108,514)	(92,104)
Cash Flows from Financing Activities
Net change in deposits	60,754	87,689
Net change in federal funds purchased and securities sold under agreements to repurchase	2,412	(167)
Repayment of FHLB advances	(1,388)	(157)
Purchase of treasury stock		(23)
Cash dividends paid on common stock	(2,462)	(1,889)
Net cash provided by financing activities	59,316	85,453
Net Decrease in Cash and Cash Equivalents	(41,301)	(206)
Cash and Cash Equivalents - Beginning of year	180,823	175,706	175,706
Cash and Cash Equivalents - End of period	139,522	175,500	$ 180,823
Supplemental cash flow information:
Interest paid	3,057	1,573
Supplemental noncash disclosures:
Transfer of loans to other real estate owned		148
Cash dividends declared not paid	$ 2,462	$ 1,889